VTGN
VistaGen Therapeutics Inc.
NASDAQ · Healthcare
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||||
| Capital Expenditures | — | — | — | 200,400 | 275,400 | 0 | 174,000 | 1,600 | — | — | — | — | — |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||||
| Free Cash Flow | — | — | — | -45.5M | -12.3M | -15.8M | -14.7M | -9.1M | — | — | — | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — |